Legal regulations of complementary and alternative medicines in different countries

Pharmacognosy Reviews

Volumn 6, Issue 12, 2012, Pages 154-160

  Ajazuddin, ^a   Saraf, Shailendra ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Efficacy; legislation; quality; safety; traditional medicines

Indexed keywords

ALTERNATIVE MEDICINE; CHINESE MEDICINE; DRUG EFFICACY; DRUG MANUFACTURE; DRUG QUALITY; DRUG SAFETY; EUROPEAN UNION; HERBAL MEDICINE; HUMAN; JAPANESE MEDICINE; LEGAL ASPECT; LICENSING; PLANT PRODUCT; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; TRADITIONAL MEDICINE; WORLD HEALTH ORGANIZATION;

EID: 84866705482     PISSN: 09737847     EISSN: 09762787     Source Type: Journal    
DOI: 10.4103/0973-7847.99950     Document Type: Review

References (70)

1. World Health Organization. Research Guidelines for Evaluating the Safety and Effi cacy of Herbal Medicines. Manila: 1993.
2. World Health Organization. Regulatory Situation of Herbal Medicines. A Worldwide Review (WHO/trm/98.1). Geneva, 1998.
3. Schulz V, Hänsel R, Tyler VE. Rational Phytotherapy. A Physician's Guide to Herbal Medicine. 4th ed. Berlin: Springer; 2001.
4. Li L. Opportunity and challenge of traditional Chinese medicine in face of the entrance to World Trade Organization. Chin Inform trad Chin Med 2000;7:7-8.
5. Saito H. Regulation of herbal medicines in Japan. Pharmacol Regul 2000;41:515-9.
6. Morgan K. Medicine of the Gods: Basic Principles of Ayurvedic Medicine, 2002. Available from: http://www.compulink.co.uk/mandrake/ayurveda.htm. [Last accessed on 2010 Jul 02].
7. World Health Organization. Regulatory Situation of Herbal Medicines. A Worldwide Review. Geneva: World Health Organization; 1998.
8. World Health Organization. Guidelines on safety monitoring of herbal medicines in pharmacovigilance systems 2004.
9. World Health Organization. Guidelines for the Regulation of Herbal Medicines in the South-East Asia Region. 2003.
10. World Health Organization. General guidelines for methodologies on research and evaluation of traditional medicine. Geneva: WHO; 2000.
11. World Health Organization. National policy on traditional medicine and regulation of herbal medicines Report of a WHO global survey 2005.
12. World Health Organization. Traditional Medicine Strategy. 2002-2005.
13. World Health Organization. Guidelines on good agricultural and collection practices (GACP) for medicinal plants. 2003.
14. AESGP (Association Européenne des Spécialités Pharmaceutiques Grand Public; The Association of the European Self-Medication Industry) 1998.
15. European Commission Council Directive 65/65/EEC on the approximation of provisions laid down by Law, Regulation or Administrative Action relation to proprietary medicinal products. Off J 1965;22:369-73.
16. Briggs DR. The regulation of herbal medicines in Australia. Toxicology 2002;181-182:565-70.
17. Therapeutic Goods Administration Medicines Regulation and the TGA. Woden, ACT, Australia; 1999.
18. Xiaorui Z. Regulatory situation of herbal medicines: A worldwide review. Tradit Med Program 1998;1-45.
19. Regulation of the Minister of Health, Sports and Consumer Protection, the Regulation concerning facilitation of the admission of certain Medicinal products is changed. Federal Law Gazette Republic of Austria, 1992, 3912-5.
20. Regulation of the Minister for Health and Public Service and the Federal Minister for Economic Affairs of 21 November 1989 on the tax and labeling of certain drugs in the retail selling (Delimitation Regulation). Federal Law Gazette of the Republic Austria, 1989; 4049-78.
21. Sofi a, Bulgaria; Information letter of the Ministry of Health, National Drug Institute. dated 1996 Feb 07.
22. Ministry of Public Health and Environment. Ministerial circular instructions to the constitution of the fi le registration of herbal medicines. monitor Belgian 1995 and 3103-9.
23. Ministry of Public Health and Environment. Circular Ministerial nE 367, 1989.
24. Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: Challenges, and opportunities to increase 2 the knowledge base for safety assessment. Toxicol Appl Pharmacol 2010:243:198-216.
25. Johnson T. Chinese medicine now part of primary care scene in BC. CMAJ 2001;164:1195.
26. Sibbald B. New federal offi ce will spend millions to regulate herbal remedies, vitamins. CMAJ 1999;160:1355-7.
27. Kozyrskyj A. Herbal products in Canada. How safe are they. Can Fam Physician. 1997;43:697-702.
28. Calixto JB. Effi cacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 2000;33:179-89.
29. Ministry of Health of the Republic of Colombia resolution Number 1990.
30. Order on herbal medicines. Ministry of Health. No. 1992; 790.
31. NLN Regulatory Seminars in Quality Assessment of Natural Remedies. NLN Publication No. 40. Uppsala: Nordic Council on Medicines; 1996.
32. Procedure for registration of medicinal products and approval of variations to the terms of registered medicinal products.: Estonia; 1996.
33. Bailey M. Communication of the Ministry of Health, Suva, Fiji, with World Health Organization. 1996.
34. The NSW Therapeutic Medicines Information Centre. The uncertain world of "herbal" medication-A drug information viewpoint. Drug Bull 1993;19.
35. Commission Directive 91/507/EEC of 19 July 1991 modifying the Annex to Council Directive 75/318/EEC on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products. Offi cial Journal of the European Communities nE L. 270/32 of 26 Sept 1991.
36. Castot A, Djezzar S, Deleau N, Guillot B, Efthymiou ML. Drug surveillance of herbal medicines. Thérapie 1997;52:97-103.
37. Kraft K. Herbal medicine products and drug law. Forsch Komplementärmed 1999;6:19-23.
38. Sandberg F, Corrigan D. Natural remedies. Their Origins and Uses, New York: Taylor and Francis; 2001.
39. Keller K. Legal requirements for the use of phytopharmaceutical drugs in the Federal Republic of Germany. J Ethnopharmacol 1991;32:225-9.
40. Minister of health, providence and social insurance regulation. Ankara. 1994.
41. Association of European Self-Medication Consumer (AESGP), editor. Economic and Legal Framework for Non-Prescription Medicines in Europe. Brussels: AESGP,1996. p. 105-9.
42. Drug and cosmetic act, Government of India.1942.
43. Morris JM. Communication of the Irish Medicines Board with World Health Organization; 1996.
44. Guidelines for Application for Product Authorization of Herbal Products. Dublin: National Drugs Advisory Board; 1985.
45. Prodotti a base di piante medicinali. Circolare n. 1 (N. 800.7.AG.8/254). Direzione Generale del Servizio Farmaceutico Divisione VII; 1981.
46. Eguchi K, Hyodo I, Saeki H. Current status of cancer patients' perception of alternative medicine in Japan. A preliminary crosssectional survey. Support Care Cancer 2000;8:28-32.
47. Choi DW, Kim JH, Cho SY, Kim DH, Chang SY. Regulation and quality control of herbal drugs in Korea. Toxicology 2002;181-182:581-6.
48. Bonati A. Guidelines for the chemical and biological assessment of herbals and herbal preparations UNIDO. 1989;1-18 .
49. Korean Pharmacopoeia. 7th ed. Seoul, Korea: Medicine Publishers; 1997.
50. Korean Herbal Pharmacopoeia. Korea: Ministry of Health and Welfare; 1987.
51. Ministry of Health Traditional Mongolian Medicine. Information sheet. Mongolia;1996.
52. Gewali MB. Personal communication 1995 Nov 16.
53. Sotomayor U. Traditional Medicine in Nicaragua and its Integration into the Local Health Systems. Lecture held at the Morris Arboretum Symposium. Philadelphia, 1993 Apr 19-21.
54. Ministry of Health of the Sultanate of Oman. Conditions to allow import of traditional drugs. Muscat; 1995.
55. The fl our, Cachadinha M. Some considerations on the Portuguese legislation, Herbal Medicine. LEF in July 1994. 2
56. World Health Organization Guidelines for the Assessment of Herbal Medicines (WHO Technical Report Series No. 863). Geneva: WHO; 1996.
57. World Health Organization Western Pacifi c Regional Offi ce (WPRO). 1996.
58. Pharmaceutical Department of the Ministry of Health of Singapore. Communication with WHO 1996 Mar 13.
59. Des Medicines Act, Madrid, Art 42.Ley25/1990.
60. Order of October 3, 1973 by establishing the record special preparations of vegetables species medicinal. Ministry of the Interior. BOE 247 of 15 nE October, Madrid, 1973.
61. Communications from the ICS. ICS monthly report of Bern, 1992;6:345.
62. Griffi n JP. The evolution of human medicines control from a national to an international perspective. Adverse Drug React Toxicol Rev 1998;17:19-50.
63. Ministry of Agriculture, Fisheries and Food (MAFF) Herb Legislation. London: Herb Society; 1998.
64. Mills SY. The House of Lords report on complementary medicine: A summary. Complement Ther Med 2001;9:34-9.
65. Shaw D. Risks or remedies? Safety aspects of herbal remedies. J R Soc Med 1998;91:294-6.
66. De Smet PA. Should herbal medicine-like products be licensed as medicines. BMJ 1995;310:1023-4.
67. Chang J. Scientifi c evaluation of traditional Chinese medicine under DSHEA: A conundrum. Dietary Supplement Health and Education Act. J Altern Complement Med 1999;5:181-9.
68. Angell M, Kassirer JP. Alternative medicine-the risks of untested and unregular remedies. N Engl J Med 1998;339:839-41.
69. Goldman SA, Kennedy DL. FDA's Medical Products Reporting Program. A joint effort toward improved public health. Postgrad Med 1998;103:13-6.
70. Food and Drug Administration, Guidance for Industry: Botanical Drug Products, Washington DC, Center for Drug Evaluation and Research 2000. Available from: http://www.fda.gov/cder/guidance/index.htm [Last accessed on 2010 Jul 02].